Tang L - Search Results

1

Plasma proteomic and metabolomic signatures of B-ALL patients during CAR-T cell therapy.

Wu J, Tang L, Du M, Li C, Kou H, Jiang H, Luo W, Zhang Y, Huang Z, Liao D, Xiong W, Mei H, Hu Y. Wu J, et al. Among authors: tang l. Clin Transl Med. 2023 Mar;13(3):e1225. doi: 10.1002/ctm2.1225. Clin Transl Med. 2023. PMID: 36938989 Free PMC article. No abstract available.

2

Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis.

Tang L, Peng YZ, Li CG, Jiang HW, Mei H, Hu Y. Tang L, et al. J Cancer. 2019 Jan 1;10(3):654-664. doi: 10.7150/jca.28537. eCollection 2019. J Cancer. 2019. PMID: 30719163 Free PMC article. Review.

3

Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trial.

Jiang H, Li C, Yin P, Guo T, Liu L, Xia L, Wu Y, Zhou F, Ai L, Shi W, Lu X, Wang H, Tang L, Wei Q, Deng J, Jin R, Xiong W, Dong J, Mei H, Hu Y. Jiang H, et al. Among authors: tang l. Am J Hematol. 2019 Oct;94(10):1113-1122. doi: 10.1002/ajh.25582. Epub 2019 Aug 2. Am J Hematol. 2019. PMID: 31321805 Free article. Clinical Trial.

4

Comparative efficacy and tolerability of front-line treatments for newly diagnosed chronic-phase chronic myeloid leukemia: an update network meta-analysis.

Tang L, Zhang H, Peng YZ, Li CG, Jiang HW, Xu M, Mei H, Hu Y. Tang L, et al. BMC Cancer. 2019 Aug 28;19(1):849. doi: 10.1186/s12885-019-6039-9. BMC Cancer. 2019. PMID: 31462241 Free PMC article.

5

Fibrinogen levels are associated with bleeding in patients with primary immune thrombocytopenia.

Xu M, Luo L, Du M, Tang L, Hu Y, Mei H. Xu M, et al. Among authors: tang l. Platelets. 2020 Aug 17;31(6):763-770. doi: 10.1080/09537104.2019.1678115. Epub 2019 Oct 15. Platelets. 2020. PMID: 31610686 Free article.

6

Characterization of Immune Dysfunction and Identification of Prognostic Immune-Related Risk Factors in Acute Myeloid Leukemia.

Tang L, Wu J, Li CG, Jiang HW, Xu M, Du M, Yin Z, Mei H, Hu Y. Tang L, et al. Clin Cancer Res. 2020 Apr 1;26(7):1763-1772. doi: 10.1158/1078-0432.CCR-19-3003. Epub 2020 Jan 7. Clin Cancer Res. 2020. PMID: 31911547

7

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.

Liao D, Zhou F, Luo L, Xu M, Wang H, Xia J, Gao Y, Cai L, Wang Z, Yin P, Wang Y, Tang L, Deng J, Mei H, Hu Y. Liao D, et al. Among authors: tang l. Lancet Haematol. 2020 Sep;7(9):e671-e678. doi: 10.1016/S2352-3026(20)30217-9. Epub 2020 Jul 10. Lancet Haematol. 2020. PMID: 32659214 Free PMC article.

8

Controlling Cytokine Storm Is Vital in COVID-19.

Tang L, Yin Z, Hu Y, Mei H. Tang L, et al. Front Immunol. 2020 Nov 30;11:570993. doi: 10.3389/fimmu.2020.570993. eCollection 2020. Front Immunol. 2020. PMID: 33329533 Free PMC article. Review.

9

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies.

Tang L, Zhang Y, Hu Y, Mei H. Tang L, et al. Biomed Res Int. 2021 Feb 25;2021:6616391. doi: 10.1155/2021/6616391. eCollection 2021. Biomed Res Int. 2021. PMID: 33728333 Free PMC article. Review.

10

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report.

Li C, Sun Y, Wang J, Tang L, Jiang H, Guo T, Liu L, Wu Y, Ai L, Xia L, Wu J, Lin Z, Qian Q, Hu Y, Mei H. Li C, et al. Among authors: tang l. Front Immunol. 2021 May 25;12:599493. doi: 10.3389/fimmu.2021.599493. eCollection 2021. Front Immunol. 2021. PMID: 34113336 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,851 results

Search Page

Filters